22nd Century Net Profit Margin 2012-2026 | XXII
22nd Century net profit margin from 2012 to 2026. Net profit margin can be defined as net Income as a portion of total sales revenue.
| 22nd Century Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2026-06-30 | $0.02B | $-0.04B | -233.33% |
| 2026-03-31 | $0.02B | $-0.02B | -100.00% |
| 2025-12-31 | $0.02B | $-0.01B | -50.00% |
| 2025-09-30 | $0.02B | $-0.01B | -50.00% |
| 2025-06-30 | $0.02B | $-0.02B | -105.00% |
| 2025-03-31 | $0.02B | $-0.02B | -83.33% |
| 2024-12-31 | $0.02B | $-0.03B | -104.17% |
| 2024-09-30 | $0.03B | $-0.06B | -207.41% |
| 2024-06-30 | $0.03B | $-0.12B | -420.69% |
| 2024-03-31 | $0.03B | $-0.14B | -486.21% |
| 2023-12-31 | $0.03B | $-0.15B | -468.75% |
| 2023-09-30 | $0.02B | $-0.14B | -600.00% |
| 2023-06-30 | $0.03B | $-0.08B | -229.41% |
| 2023-03-31 | $0.04B | $-0.07B | -170.00% |
| 2022-12-31 | $0.04B | $-0.06B | -147.50% |
| 2022-09-30 | $0.05B | $-0.05B | -94.00% |
| 2022-06-30 | $0.04B | $-0.04B | -110.26% |
| 2022-03-31 | $0.03B | $-0.04B | -109.09% |
| 2021-12-31 | $0.03B | $-0.03B | -103.23% |
| 2021-09-30 | $0.03B | $-0.02B | -80.00% |
| 2021-06-30 | $0.03B | $-0.02B | -65.52% |
| 2021-03-31 | $0.03B | $-0.02B | -74.07% |
| 2020-12-31 | $0.03B | $-0.02B | -70.37% |
| 2020-09-30 | $0.03B | $-0.02B | -70.37% |
| 2020-06-30 | $0.03B | $-0.03B | -96.15% |
| 2020-03-31 | $0.03B | $-0.03B | -107.69% |
| 2019-12-31 | $0.03B | $-0.03B | -104.00% |
| 2019-09-30 | $0.03B | $-0.03B | -116.00% |
| 2019-06-30 | $0.03B | $-0.01B | -52.00% |
| 2019-03-31 | $0.03B | $-0.01B | -46.15% |
| 2018-12-31 | $0.03B | $-0.01B | -34.62% |
| 2018-09-30 | $0.03B | $0.00B | -16.00% |
| 2018-06-30 | $0.02B | $-0.01B | -54.17% |
| 2018-03-31 | $0.02B | $-0.01B | -42.86% |
| 2017-12-31 | $0.02B | $-0.01B | -76.47% |
| 2017-09-30 | $0.01B | $-0.01B | -85.71% |
| 2017-06-30 | $0.01B | $-0.01B | -100.00% |
| 2017-03-31 | $0.01B | $-0.01B | -109.09% |
| 2016-12-31 | $0.01B | $-0.01B | -100.00% |
| 2016-09-30 | $0.01B | $-0.01B | -100.00% |
| 2016-06-30 | $0.01B | $-0.01B | -100.00% |
| 2016-03-31 | $0.01B | $-0.01B | -90.91% |
| 2015-12-31 | $0.01B | $-0.01B | -122.22% |
| 2015-09-30 | $0.01B | $-0.01B | -233.33% |
| 2015-06-30 | $0.00B | $-0.01B | -466.67% |
| 2015-03-31 | $0.00B | $-0.02B | -1500.00% |
| 2014-12-31 | $0.00B | $-0.02B | 0.00% |
| 2014-09-30 | $0.01B | $-0.02B | -257.14% |
| 2014-06-30 | $0.01B | $-0.03B | -428.57% |
| 2013-09-30 | $0.00B | $-0.02B | 0.00% |
| 2012-09-30 | $0.00B | $0.00B | 0.00% |
| 2011-12-31 | $0.00B | $0.00B | -100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Consumer Staples | Tobacco Products | $0.001B | $0.018B |
| 22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Philip Morris (PM) | United States | $302.542B | 23.96 |
| Altria (MO) | United States | $116.565B | 12.58 |
| British American Tobacco (BTI) | United Kingdom | $114.738B | 0.00 |
| JAPAN TOB (JAPAY) | Japan | $77.655B | 24.03 |
| Imperial Tobacco Group (IMBBY) | United Kingdom | $25.912B | 0.00 |
| Turning Point Brands (TPB) | United States | $1.356B | 30.05 |
| Universal (UVV) | United States | $1.104B | 21.42 |
| Air Global (AIIR) | United States | $0.288B | 0.00 |
| Ispire Technology (ISPR) | United States | $0.083B | 0.00 |